FDA Warning Letter — BioReliance Corporation
The FDA took a Warning Letter action against BioReliance Corporation on January 5, 2009 (Rockville, MD). The action was issued by CBER and concerns biologics products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- BioReliance Corporation
- Date
- January 5, 2009
- Fiscal Year
- 2009
- Product Type
- Biologics
- Center
- CBER
- Location
- Rockville, MD (United States)